Adapalene NDC 49908-118

NDC codes

FDA NDC Directory

Product NDC (as listed)49908-118Labeler and product segments. Claims need a package NDC.

Product NDC at billing width49908-0118Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
49908-118-14	49908011814	14 POUCH in 1 CARTON (49908-118-14) / 1.2 mL in 1 POUCH (49908-118-00)Marketed from Feb 4, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Adapalene
Generic name (nonproprietary): adapalene
Active ingredients: Adapalene — 1 mg/mL
Dosage form: Swab
Route: Topical
Labeler: CALL INC. (dba Rochester Pharmaceuticals)
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 204593
Marketing start: Feb 4, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 49908-118_2b371635-a5d6-4596-e063-6394a90a8ee6SPL ID 2b371635-a5d6-4596-e063-6394a90a8ee6SPL set ID 5ce78048-0e5c-45b5-82bf-9f61307611cdRxCUI 798061UNII 1L4806J2QF
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N449908011814 followed by a unit qualifier and the quantity

Package 49908-0118-14. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 8, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Adapalene Topical Solution, 0.1% is indicated for the topical treatment of acne vulgaris.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)